Trauma-focused treatments for refugee children: study protocol for a randomized controlled trial of the effectiveness of KIDNET versus EMDR therapy versus a waitlist control group (KIEM).


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
23 Apr 2022
Historique:
received: 13 01 2022
accepted: 16 03 2022
entrez: 24 4 2022
pubmed: 25 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Prevalence of posttraumatic stress disorder (PTSD) in refugees is reportedly higher in comparison to the general population. Refugee children specifically are often coping with trauma and loss and are at risk for mental health difficulties. With staggering numbers of people seeking refuge around the world and 50% being 18 years or younger, research examining the effects of trauma-focused therapies for refugee children with PTSD is highly needed. Both Eye Movement Desensitization and Reprocessing (EMDR) therapy and the child version of Narrative Exposure Therapy (KIDNET) have been used for refugees, although these treatment methods have not been systematically compared. The aim of the current study is to investigate the effectiveness of EMDR and KIDNET, compared to a waitlist control group and with each other, offered to refugee children. A randomized controlled three-arm trial has been designed. The primary outcome is PTSD diagnosis and symptom severity assessed with the Clinician-Administered PTSD Scale for Children DSM5 (CAPS-CA-5) at baseline (T1), 1 month post-treatment, or after 8 weeks of waiting (T2) and 3 months follow-up (T3). Additionally, instruments to assess posttraumatic stress symptoms, behavioral and emotional problems, and quality of life perception in children aged 8-18 are conducted at T1, T2, and T3. This is the first RCT that examines the effectiveness of EMDR and KIDNET in refugee children aged 8-18 years specifically, compared to a waitlist control group intended to reduce PTSD diagnosis and severity of posttraumatic stress symptoms and comorbid complaints in a growing and challenging population. Dutch Trial Register NL40769 . Retrospectively registered on June 16, 2021.

Sections du résumé

BACKGROUND BACKGROUND
Prevalence of posttraumatic stress disorder (PTSD) in refugees is reportedly higher in comparison to the general population. Refugee children specifically are often coping with trauma and loss and are at risk for mental health difficulties. With staggering numbers of people seeking refuge around the world and 50% being 18 years or younger, research examining the effects of trauma-focused therapies for refugee children with PTSD is highly needed. Both Eye Movement Desensitization and Reprocessing (EMDR) therapy and the child version of Narrative Exposure Therapy (KIDNET) have been used for refugees, although these treatment methods have not been systematically compared. The aim of the current study is to investigate the effectiveness of EMDR and KIDNET, compared to a waitlist control group and with each other, offered to refugee children.
METHODS METHODS
A randomized controlled three-arm trial has been designed. The primary outcome is PTSD diagnosis and symptom severity assessed with the Clinician-Administered PTSD Scale for Children DSM5 (CAPS-CA-5) at baseline (T1), 1 month post-treatment, or after 8 weeks of waiting (T2) and 3 months follow-up (T3). Additionally, instruments to assess posttraumatic stress symptoms, behavioral and emotional problems, and quality of life perception in children aged 8-18 are conducted at T1, T2, and T3.
DISCUSSION CONCLUSIONS
This is the first RCT that examines the effectiveness of EMDR and KIDNET in refugee children aged 8-18 years specifically, compared to a waitlist control group intended to reduce PTSD diagnosis and severity of posttraumatic stress symptoms and comorbid complaints in a growing and challenging population.
TRIAL REGISTRATION BACKGROUND
Dutch Trial Register NL40769 . Retrospectively registered on June 16, 2021.

Identifiants

pubmed: 35461281
doi: 10.1186/s13063-022-06178-z
pii: 10.1186/s13063-022-06178-z
pmc: PMC9034070
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

347

Subventions

Organisme : ZonMw
ID : 636601003
Pays : Netherlands
Organisme : Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes- en Zenuwzieken
ID : 288

Informations de copyright

© 2022. The Author(s).

Références

Eur J Psychotraumatol. 2019 Mar 25;10(1):1550344
pubmed: 31007868
Lancet. 2012 Jan 21;379(9812):266-82
pubmed: 21835459
Infant Ment Health J. 2012 Sep;33(5):459-468
pubmed: 28520264
BMC Psychiatry. 2009 May 13;9:22
pubmed: 19439099
J Child Psychol Psychiatry. 2020 Jan;61(1):18-29
pubmed: 31313834
JAMA Pediatr. 2015 Aug;169(8):761-9
pubmed: 26111066
J Consult Clin Psychol. 2004 Aug;72(4):579-87
pubmed: 15301642
Eur J Psychotraumatol. 2019 Jan 17;10(1):1558708
pubmed: 30693077
J Trauma Stress. 2014 Jun;27(3):338-44
pubmed: 24797017
Clin Child Psychol Psychiatry. 2020 Jan;25(1):213-226
pubmed: 31315450
J Child Psychol Psychiatry. 2013 Nov;54(11):1231-41
pubmed: 23738530
Psychother Res. 2021 Jul;31(6):695-710
pubmed: 33205713
Eur J Psychotraumatol. 2018 Nov 22;9(1):1546085
pubmed: 30510643
Eur J Psychotraumatol. 2017 Nov 07;8(sup2):1388709
pubmed: 29163868
Curr Psychiatry Rep. 2013 Feb;15(2):341
pubmed: 23307563
J Am Acad Child Adolesc Psychiatry. 2013 Apr;52(4):359-69
pubmed: 23582867
Psychosom Med. 1979 May;41(3):209-18
pubmed: 472086
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
J Clin Psychiatry. 2000;61 Suppl 5:4-12; discussion 13-4
pubmed: 10761674
Eur Child Adolesc Psychiatry. 2019 Oct;28(10):1295-1310
pubmed: 30151800
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
BMC Psychiatry. 2005 Feb 03;5:7
pubmed: 15691374
Child Adolesc Psychiatry Ment Health. 2008 May 29;2(1):12
pubmed: 18510770
Epidemiol Psychiatr Sci. 2018 Apr;27(2):117-123
pubmed: 29122044
Eur Child Adolesc Psychiatry. 2013 May;22(5):269-83
pubmed: 23266844
J Trauma Stress. 2010 Aug;23(4):437-45
pubmed: 20684019
Nord J Psychiatry. 2004;58(3):199-203
pubmed: 15204206
Eur J Psychotraumatol. 2013 May 02;4:
pubmed: 23671763
JAMA. 2011 Aug 3;306(5):503-12
pubmed: 21813428

Auteurs

Merel E Velu (ME)

ARQ Centrum'45, partner in ARQ National Psychotrauma Centre, Diemen, The Netherlands. m.velu@centrum45.nl.
Department of Clinical Psychology, Utrecht University, Utrecht, The Netherlands. m.velu@centrum45.nl.

Irene Martens (I)

ARQ Centrum'45, partner in ARQ National Psychotrauma Centre, Oegstgeest, The Netherlands.

Mona Shahab (M)

Department of Clinical Psychology, Leiden University, Leiden, The Netherlands.
Department of Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
King Salman Center for Disability Research, Riyadh, Saudi Arabia.

Carlijn de Roos (C)

Department of Child and Adolescent Psychiatry, Amsterdam University Medical Centre, Amsterdam, the Netherlands.

Ruud A Jongedijk (RA)

ARQ Centrum'45, partner in ARQ National Psychotrauma Centre, Diemen, The Netherlands.

Michaela Schok (M)

ARQ Centrum'45, partner in ARQ National Psychotrauma Centre, Diemen, The Netherlands.
Department of Clinical Psychology, Utrecht University, Utrecht, The Netherlands.

T Mooren (T)

ARQ Centrum'45, partner in ARQ National Psychotrauma Centre, Diemen, The Netherlands.
Department of Clinical Psychology, Utrecht University, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH